Clinical Trial

A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181

Name: A Clinical Study Evaluating the Preliminary Anti-tumor Efficacy and Safety of Hemay181 — clinical trial record (NCT07446816)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.

Trial Details

NCT Number	NCT07446816
Lead Sponsor	Ganzhou Hemay Pharmaceutical Co., Ltd
Conditions	Advanced Solid Tumors
Enrollment	24 participants
Start Date	2025-12-03
Primary Completion	2026-08 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-03-03